Cancer Biopsy Market Size & Share – Trends Report, 2032

Cancer Biopsy Market – By Biopsy Type (Tissue [Needle, Surgical], Liquid, Image-guided), Product & Services (Product [Biopsy Needle/Guns, Biopsy Forceps], Services), Cancer Type (Breast, Colorectal, Lung), End-user – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of cancer

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in cancer biopsy techniques

3.2.1.3&nbsp;&nbsp;&nbsp; Rising awareness in inherited oncology disorders and genetic testing

3.2.1.4&nbsp;&nbsp;&nbsp; Expansion of research and development

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of biopsy devices

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory requirements

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technology landscape

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Biopsy Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Tissue biopsy

5.2.1&nbsp;&nbsp;&nbsp; Needle biopsy

5.2.2&nbsp;&nbsp;&nbsp; Surgical biopsy

5.2.3&nbsp;&nbsp;&nbsp; Other tissue biopsy types

5.3&nbsp;&nbsp;&nbsp; Liquid biopsy

5.3.1&nbsp;&nbsp;&nbsp; Circulating tumor cells (CTCs)

5.3.2&nbsp;&nbsp;&nbsp; Circulating tumor DNA (ctDNA)

5.3.3&nbsp;&nbsp;&nbsp; Other liquid biopsy types

5.4&nbsp;&nbsp;&nbsp; Image-guided biopsy

5.5&nbsp;&nbsp;&nbsp; Other biopsy types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Products &amp; Services, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Products

6.2.1&nbsp;&nbsp;&nbsp; Biopsy needles/ guns

6.2.1.1&nbsp;&nbsp;&nbsp; Fine needle aspiration (FNA)

6.2.1.2&nbsp;&nbsp;&nbsp; Core needle biopsy (CNB)

6.2.1.3&nbsp;&nbsp;&nbsp; Vacuum-assisted biopsy devices

6.2.2&nbsp;&nbsp;&nbsp; Biopsy forceps

6.2.2.1&nbsp;&nbsp;&nbsp; General biopsy forceps

6.2.2.2&nbsp;&nbsp;&nbsp; Hot biopsy forceps

6.2.3&nbsp;&nbsp;&nbsp; Kits and reagents

6.2.4&nbsp;&nbsp;&nbsp; Consumables

6.3&nbsp;&nbsp;&nbsp; Services

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Cancer Type, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Breast cancer

7.3&nbsp;&nbsp;&nbsp; Colorectal cancer

7.4&nbsp;&nbsp;&nbsp; Stomach cancer

7.5&nbsp;&nbsp;&nbsp; Lung cancer

7.6&nbsp;&nbsp;&nbsp; Liver cancer

7.7&nbsp;&nbsp;&nbsp; Prostate cancer

7.8&nbsp;&nbsp;&nbsp; Ovarian cancer

7.9&nbsp;&nbsp;&nbsp; Other cancer types

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-user, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Cancer research centers

8.4&nbsp;&nbsp;&nbsp; Diagnostic centers

8.5&nbsp;&nbsp;&nbsp; Research and academics

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; ANGLE plc.

10.2&nbsp;&nbsp;&nbsp; BD (Becton, Dickinson and Company)

10.3&nbsp;&nbsp;&nbsp; Biodesix (Integrated Diagnostics)

10.4&nbsp;&nbsp;&nbsp; Chronix Biomedical, Inc (Oncocyte Corporation )

10.5&nbsp;&nbsp;&nbsp; Devicor Medical Products, Inc.

10.6&nbsp;&nbsp;&nbsp; GRAIL, Inc.

10.7&nbsp;&nbsp;&nbsp; Hologic, Inc.

10.8&nbsp;&nbsp;&nbsp; Illumina, Inc.

10.9&nbsp;&nbsp;&nbsp; IZI Medical Products

10.10&nbsp;&nbsp;&nbsp; Lucence Health Inc.

10.11&nbsp;&nbsp;&nbsp; Myriad Genetics, Inc.

10.12&nbsp;&nbsp;&nbsp; Oncimmune Holdings PLC

10.13&nbsp;&nbsp;&nbsp; Personal Genome Diagnostics Inc.

10.14&nbsp;&nbsp;&nbsp; QIAGEN N.V. 
&nbsp;

Cancer Biopsy Market

Get a free sample of this report